Clinical trial

XIGDUO Extended Release (XR) Post Marketing Surveillance

NCT03038789

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2017-04-20

PhaseN/A

Study timeline

Study start (actual)2017-04-20Date precision: day

Registry last updated2020-07-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Adult Patients With Type 2 Diabetes Mellitusunresolved

Interventions

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

SeoulSouth Korea1 DaeguSouth Korea1 BusanSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03038789 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.